Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Application site discolouration: Which Medications Cause It? (2,951 Reports Across 83 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Application site discolouration has been reported as an adverse event with 83 different drugs in the FDA's FAERS database, with 2,951 total reports. 4 of these reports resulted in death.The drugs most commonly associated with Application site discolouration are SUMATRIPTAN, BUPRENORPHINE, and INGENOL MEBUTATE.

2,951
Total Reports
83
Drugs Involved
4
Deaths
88
Hospitalizations
49.6 yrs
Average Patient Age
77.5% / 22.5%
Female / Male

Which Drugs Cause Application site discolouration Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
SUMATRIPTAN 684 3.9% 0 2 0
BUPRENORPHINE 208 0.3% 0 1 0
INGENOL MEBUTATE 115 3.8% 0 0 0
MECHLORETHAMINE 101 3.9% 1 2 0
ESTRADIOL 89 0.3% 0 0 0
NICOTINE 87 0.3% 0 1 0
MINOXIDIL 76 0.1% 0 1 0
SALICYLIC ACID 76 3.5% 0 1 0
BECAPLERMIN 74 3.6% 0 8 0
DICLOFENAC 67 0.1% 0 4 0
METHYLPHENIDATE 61 0.2% 0 0 0
PEGFILGRASTIM 61 0.1% 0 0 0
ESTRADIOL\NORETHINDRONE 54 1.3% 0 0 0
HYDROGEN PEROXIDE 51 11.8% 0 1 0
FENTANYL 42 0.0% 0 0 1
ETHINYL ESTRADIOL\NORELGESTROMIN 41 0.6% 0 0 0
OXYTROL FOR WOMEN 41 1.4% 0 0 0
DOCOSANOL 38 0.5% 0 0 0
RIVASTIGMINE 37 0.4% 1 5 0
CRISABOROLE 32 0.4% 0 0 0

View all 83 drugs →

Top 3 Drugs Associated With Application site discolouration

684 reports
208 reports
115 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)